My Eye Dr. - Medicare Optometrist in Manassas, VA

My Eye Dr. is a medicare enrolled "Optometrist" provider in Manassas, Virginia. Their current practice location is 9675 Liberia Ave, # 108, Manassas, Virginia. You can reach out to their office (for appointments etc.) via phone at (703) 331-2122.

My Eye Dr. is licensed to practice in Virginia (license number ) and it also participates in the medicare program. My Eye Dr. is enrolled with medicare and should accept medicare assignments and since they are enrolled in medicare, they may order Medicare Part D Prescription drugs, if eligible. The facility's NPI Number is 1245560655.

Contact Information

My Eye Dr.
9675 Liberia Ave, # 108,
Manassas, VA 20110-1741
(703) 331-2122
(703) 331-0534



Healthcare Provider's Profile

Full NameMy Eye Dr.
TypeFacility
SpecialityOptometrist
Location9675 Liberia Ave, Manassas, Virginia
Accepts Medicare AssignmentsMedicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1245560655
  • Provider Enumeration Date: 01/07/2010
  • Last Update Date: 05/25/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 9830375278
  • Enrollment ID: O20110519000027

Medical Identifiers

Medical identifiers for My Eye Dr. such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1245560655NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
152W00000XOptometrist (Virginia)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. My Eye Dr. acts as a billing entity for following providers:
Provider NameGregory J Katchuk
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1023190030
PECOS PAC ID: 8325036866
Enrollment ID: I20040504000722

News Archive

Obecure enters into licensing and clinical supply agreement with Grunenthal's subsidiary for XR betahistine

Obecure Ltd (http://www.obecure.com)., a subsidiary of Bio-Light Israeli Life Science Investments Ltd., announced today the execution of a licensing and clinical supply agreement with Farmaceutici Formenti SPA, the Italian Subsidiary of the Grunenthal Group.

USANA Health Sciences congratulates USANA-sponsored Olympian Steve Hooker of Australia

USANA Health Sciences, Inc. would like to congratulate USANA-sponsored Olympian Steve Hooker of Australia for his gold medal finish at the track and field world championships in Berlin, Germany.

First-of-its-kind patient, healthcare provider support program for management of HE

Concentric Pharma Advertising, an independent healthcare advertising and marketing agency, announces the creation of Salix Pharmaceuticals' Hepatic Encephalopathy Living Program. H.E.L.P. launched May 24, 2010, and coincides with the launch of Xifaxan550 (rifaximin) for the management of patients 18 or older at risk for overt hepatic encephalopathy recurrence.

Half as many people are trying heroin, but marijuana use grows

Some good news from the front lines of the heroin crisis: Half as many people tried heroin for the first time in 2017 as in 2016. That's according to data released Friday from the government's annual National Survey on Drug Use and Health.

Read more Medical News

› Verified 9 days ago

Provider NameNeda Farahmand
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1629098439
PECOS PAC ID: 8628164365
Enrollment ID: I20071011000229

News Archive

Obecure enters into licensing and clinical supply agreement with Grunenthal's subsidiary for XR betahistine

Obecure Ltd (http://www.obecure.com)., a subsidiary of Bio-Light Israeli Life Science Investments Ltd., announced today the execution of a licensing and clinical supply agreement with Farmaceutici Formenti SPA, the Italian Subsidiary of the Grunenthal Group.

USANA Health Sciences congratulates USANA-sponsored Olympian Steve Hooker of Australia

USANA Health Sciences, Inc. would like to congratulate USANA-sponsored Olympian Steve Hooker of Australia for his gold medal finish at the track and field world championships in Berlin, Germany.

First-of-its-kind patient, healthcare provider support program for management of HE

Concentric Pharma Advertising, an independent healthcare advertising and marketing agency, announces the creation of Salix Pharmaceuticals' Hepatic Encephalopathy Living Program. H.E.L.P. launched May 24, 2010, and coincides with the launch of Xifaxan550 (rifaximin) for the management of patients 18 or older at risk for overt hepatic encephalopathy recurrence.

Half as many people are trying heroin, but marijuana use grows

Some good news from the front lines of the heroin crisis: Half as many people tried heroin for the first time in 2017 as in 2016. That's according to data released Friday from the government's annual National Survey on Drug Use and Health.

Read more Medical News

› Verified 9 days ago

Provider NameFrank Cassella
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1104018746
PECOS PAC ID: 2365527314
Enrollment ID: I20080314000281

News Archive

Obecure enters into licensing and clinical supply agreement with Grunenthal's subsidiary for XR betahistine

Obecure Ltd (http://www.obecure.com)., a subsidiary of Bio-Light Israeli Life Science Investments Ltd., announced today the execution of a licensing and clinical supply agreement with Farmaceutici Formenti SPA, the Italian Subsidiary of the Grunenthal Group.

USANA Health Sciences congratulates USANA-sponsored Olympian Steve Hooker of Australia

USANA Health Sciences, Inc. would like to congratulate USANA-sponsored Olympian Steve Hooker of Australia for his gold medal finish at the track and field world championships in Berlin, Germany.

First-of-its-kind patient, healthcare provider support program for management of HE

Concentric Pharma Advertising, an independent healthcare advertising and marketing agency, announces the creation of Salix Pharmaceuticals' Hepatic Encephalopathy Living Program. H.E.L.P. launched May 24, 2010, and coincides with the launch of Xifaxan550 (rifaximin) for the management of patients 18 or older at risk for overt hepatic encephalopathy recurrence.

Half as many people are trying heroin, but marijuana use grows

Some good news from the front lines of the heroin crisis: Half as many people tried heroin for the first time in 2017 as in 2016. That's according to data released Friday from the government's annual National Survey on Drug Use and Health.

Read more Medical News

› Verified 9 days ago

Provider NameVincent A Bertomeu
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1003074139
PECOS PAC ID: 2961436209
Enrollment ID: I20100813000736

News Archive

Obecure enters into licensing and clinical supply agreement with Grunenthal's subsidiary for XR betahistine

Obecure Ltd (http://www.obecure.com)., a subsidiary of Bio-Light Israeli Life Science Investments Ltd., announced today the execution of a licensing and clinical supply agreement with Farmaceutici Formenti SPA, the Italian Subsidiary of the Grunenthal Group.

USANA Health Sciences congratulates USANA-sponsored Olympian Steve Hooker of Australia

USANA Health Sciences, Inc. would like to congratulate USANA-sponsored Olympian Steve Hooker of Australia for his gold medal finish at the track and field world championships in Berlin, Germany.

First-of-its-kind patient, healthcare provider support program for management of HE

Concentric Pharma Advertising, an independent healthcare advertising and marketing agency, announces the creation of Salix Pharmaceuticals' Hepatic Encephalopathy Living Program. H.E.L.P. launched May 24, 2010, and coincides with the launch of Xifaxan550 (rifaximin) for the management of patients 18 or older at risk for overt hepatic encephalopathy recurrence.

Half as many people are trying heroin, but marijuana use grows

Some good news from the front lines of the heroin crisis: Half as many people tried heroin for the first time in 2017 as in 2016. That's according to data released Friday from the government's annual National Survey on Drug Use and Health.

Read more Medical News

› Verified 9 days ago

Provider NameMonica Lynn Bishop
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1679655708
PECOS PAC ID: 2961687983
Enrollment ID: I20110505000855

News Archive

Obecure enters into licensing and clinical supply agreement with Grunenthal's subsidiary for XR betahistine

Obecure Ltd (http://www.obecure.com)., a subsidiary of Bio-Light Israeli Life Science Investments Ltd., announced today the execution of a licensing and clinical supply agreement with Farmaceutici Formenti SPA, the Italian Subsidiary of the Grunenthal Group.

USANA Health Sciences congratulates USANA-sponsored Olympian Steve Hooker of Australia

USANA Health Sciences, Inc. would like to congratulate USANA-sponsored Olympian Steve Hooker of Australia for his gold medal finish at the track and field world championships in Berlin, Germany.

First-of-its-kind patient, healthcare provider support program for management of HE

Concentric Pharma Advertising, an independent healthcare advertising and marketing agency, announces the creation of Salix Pharmaceuticals' Hepatic Encephalopathy Living Program. H.E.L.P. launched May 24, 2010, and coincides with the launch of Xifaxan550 (rifaximin) for the management of patients 18 or older at risk for overt hepatic encephalopathy recurrence.

Half as many people are trying heroin, but marijuana use grows

Some good news from the front lines of the heroin crisis: Half as many people tried heroin for the first time in 2017 as in 2016. That's according to data released Friday from the government's annual National Survey on Drug Use and Health.

Read more Medical News

› Verified 9 days ago

Provider NameJeffrey C Shelton
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1912937855
PECOS PAC ID: 6204072440
Enrollment ID: I20130415000106

News Archive

Obecure enters into licensing and clinical supply agreement with Grunenthal's subsidiary for XR betahistine

Obecure Ltd (http://www.obecure.com)., a subsidiary of Bio-Light Israeli Life Science Investments Ltd., announced today the execution of a licensing and clinical supply agreement with Farmaceutici Formenti SPA, the Italian Subsidiary of the Grunenthal Group.

USANA Health Sciences congratulates USANA-sponsored Olympian Steve Hooker of Australia

USANA Health Sciences, Inc. would like to congratulate USANA-sponsored Olympian Steve Hooker of Australia for his gold medal finish at the track and field world championships in Berlin, Germany.

First-of-its-kind patient, healthcare provider support program for management of HE

Concentric Pharma Advertising, an independent healthcare advertising and marketing agency, announces the creation of Salix Pharmaceuticals' Hepatic Encephalopathy Living Program. H.E.L.P. launched May 24, 2010, and coincides with the launch of Xifaxan550 (rifaximin) for the management of patients 18 or older at risk for overt hepatic encephalopathy recurrence.

Half as many people are trying heroin, but marijuana use grows

Some good news from the front lines of the heroin crisis: Half as many people tried heroin for the first time in 2017 as in 2016. That's according to data released Friday from the government's annual National Survey on Drug Use and Health.

Read more Medical News

› Verified 9 days ago

Provider NameLisa Abraham
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1477897346
PECOS PAC ID: 8426283920
Enrollment ID: I20140911000825

News Archive

Obecure enters into licensing and clinical supply agreement with Grunenthal's subsidiary for XR betahistine

Obecure Ltd (http://www.obecure.com)., a subsidiary of Bio-Light Israeli Life Science Investments Ltd., announced today the execution of a licensing and clinical supply agreement with Farmaceutici Formenti SPA, the Italian Subsidiary of the Grunenthal Group.

USANA Health Sciences congratulates USANA-sponsored Olympian Steve Hooker of Australia

USANA Health Sciences, Inc. would like to congratulate USANA-sponsored Olympian Steve Hooker of Australia for his gold medal finish at the track and field world championships in Berlin, Germany.

First-of-its-kind patient, healthcare provider support program for management of HE

Concentric Pharma Advertising, an independent healthcare advertising and marketing agency, announces the creation of Salix Pharmaceuticals' Hepatic Encephalopathy Living Program. H.E.L.P. launched May 24, 2010, and coincides with the launch of Xifaxan550 (rifaximin) for the management of patients 18 or older at risk for overt hepatic encephalopathy recurrence.

Half as many people are trying heroin, but marijuana use grows

Some good news from the front lines of the heroin crisis: Half as many people tried heroin for the first time in 2017 as in 2016. That's according to data released Friday from the government's annual National Survey on Drug Use and Health.

Read more Medical News

› Verified 9 days ago

Provider NameSun Hee Kim
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1932516937
PECOS PAC ID: 3072735356
Enrollment ID: I20141121001077

News Archive

Obecure enters into licensing and clinical supply agreement with Grunenthal's subsidiary for XR betahistine

Obecure Ltd (http://www.obecure.com)., a subsidiary of Bio-Light Israeli Life Science Investments Ltd., announced today the execution of a licensing and clinical supply agreement with Farmaceutici Formenti SPA, the Italian Subsidiary of the Grunenthal Group.

USANA Health Sciences congratulates USANA-sponsored Olympian Steve Hooker of Australia

USANA Health Sciences, Inc. would like to congratulate USANA-sponsored Olympian Steve Hooker of Australia for his gold medal finish at the track and field world championships in Berlin, Germany.

First-of-its-kind patient, healthcare provider support program for management of HE

Concentric Pharma Advertising, an independent healthcare advertising and marketing agency, announces the creation of Salix Pharmaceuticals' Hepatic Encephalopathy Living Program. H.E.L.P. launched May 24, 2010, and coincides with the launch of Xifaxan550 (rifaximin) for the management of patients 18 or older at risk for overt hepatic encephalopathy recurrence.

Half as many people are trying heroin, but marijuana use grows

Some good news from the front lines of the heroin crisis: Half as many people tried heroin for the first time in 2017 as in 2016. That's according to data released Friday from the government's annual National Survey on Drug Use and Health.

Read more Medical News

› Verified 9 days ago

Provider NameOanh K Bui-platten
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1639292261
PECOS PAC ID: 9032217419
Enrollment ID: I20141125000641

News Archive

Obecure enters into licensing and clinical supply agreement with Grunenthal's subsidiary for XR betahistine

Obecure Ltd (http://www.obecure.com)., a subsidiary of Bio-Light Israeli Life Science Investments Ltd., announced today the execution of a licensing and clinical supply agreement with Farmaceutici Formenti SPA, the Italian Subsidiary of the Grunenthal Group.

USANA Health Sciences congratulates USANA-sponsored Olympian Steve Hooker of Australia

USANA Health Sciences, Inc. would like to congratulate USANA-sponsored Olympian Steve Hooker of Australia for his gold medal finish at the track and field world championships in Berlin, Germany.

First-of-its-kind patient, healthcare provider support program for management of HE

Concentric Pharma Advertising, an independent healthcare advertising and marketing agency, announces the creation of Salix Pharmaceuticals' Hepatic Encephalopathy Living Program. H.E.L.P. launched May 24, 2010, and coincides with the launch of Xifaxan550 (rifaximin) for the management of patients 18 or older at risk for overt hepatic encephalopathy recurrence.

Half as many people are trying heroin, but marijuana use grows

Some good news from the front lines of the heroin crisis: Half as many people tried heroin for the first time in 2017 as in 2016. That's according to data released Friday from the government's annual National Survey on Drug Use and Health.

Read more Medical News

› Verified 9 days ago

Provider NameConstance B Campbell
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1306250923
PECOS PAC ID: 4082937529
Enrollment ID: I20150108000794

News Archive

Obecure enters into licensing and clinical supply agreement with Grunenthal's subsidiary for XR betahistine

Obecure Ltd (http://www.obecure.com)., a subsidiary of Bio-Light Israeli Life Science Investments Ltd., announced today the execution of a licensing and clinical supply agreement with Farmaceutici Formenti SPA, the Italian Subsidiary of the Grunenthal Group.

USANA Health Sciences congratulates USANA-sponsored Olympian Steve Hooker of Australia

USANA Health Sciences, Inc. would like to congratulate USANA-sponsored Olympian Steve Hooker of Australia for his gold medal finish at the track and field world championships in Berlin, Germany.

First-of-its-kind patient, healthcare provider support program for management of HE

Concentric Pharma Advertising, an independent healthcare advertising and marketing agency, announces the creation of Salix Pharmaceuticals' Hepatic Encephalopathy Living Program. H.E.L.P. launched May 24, 2010, and coincides with the launch of Xifaxan550 (rifaximin) for the management of patients 18 or older at risk for overt hepatic encephalopathy recurrence.

Half as many people are trying heroin, but marijuana use grows

Some good news from the front lines of the heroin crisis: Half as many people tried heroin for the first time in 2017 as in 2016. That's according to data released Friday from the government's annual National Survey on Drug Use and Health.

Read more Medical News

› Verified 9 days ago

Provider NameGurkiran Virdee
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1942604491
PECOS PAC ID: 1254643505
Enrollment ID: I20150630001102

News Archive

Obecure enters into licensing and clinical supply agreement with Grunenthal's subsidiary for XR betahistine

Obecure Ltd (http://www.obecure.com)., a subsidiary of Bio-Light Israeli Life Science Investments Ltd., announced today the execution of a licensing and clinical supply agreement with Farmaceutici Formenti SPA, the Italian Subsidiary of the Grunenthal Group.

USANA Health Sciences congratulates USANA-sponsored Olympian Steve Hooker of Australia

USANA Health Sciences, Inc. would like to congratulate USANA-sponsored Olympian Steve Hooker of Australia for his gold medal finish at the track and field world championships in Berlin, Germany.

First-of-its-kind patient, healthcare provider support program for management of HE

Concentric Pharma Advertising, an independent healthcare advertising and marketing agency, announces the creation of Salix Pharmaceuticals' Hepatic Encephalopathy Living Program. H.E.L.P. launched May 24, 2010, and coincides with the launch of Xifaxan550 (rifaximin) for the management of patients 18 or older at risk for overt hepatic encephalopathy recurrence.

Half as many people are trying heroin, but marijuana use grows

Some good news from the front lines of the heroin crisis: Half as many people tried heroin for the first time in 2017 as in 2016. That's according to data released Friday from the government's annual National Survey on Drug Use and Health.

Read more Medical News

› Verified 9 days ago

Provider NameDanah N. Harbi
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1972847739
PECOS PAC ID: 1456676253
Enrollment ID: I20150918001052

News Archive

Obecure enters into licensing and clinical supply agreement with Grunenthal's subsidiary for XR betahistine

Obecure Ltd (http://www.obecure.com)., a subsidiary of Bio-Light Israeli Life Science Investments Ltd., announced today the execution of a licensing and clinical supply agreement with Farmaceutici Formenti SPA, the Italian Subsidiary of the Grunenthal Group.

USANA Health Sciences congratulates USANA-sponsored Olympian Steve Hooker of Australia

USANA Health Sciences, Inc. would like to congratulate USANA-sponsored Olympian Steve Hooker of Australia for his gold medal finish at the track and field world championships in Berlin, Germany.

First-of-its-kind patient, healthcare provider support program for management of HE

Concentric Pharma Advertising, an independent healthcare advertising and marketing agency, announces the creation of Salix Pharmaceuticals' Hepatic Encephalopathy Living Program. H.E.L.P. launched May 24, 2010, and coincides with the launch of Xifaxan550 (rifaximin) for the management of patients 18 or older at risk for overt hepatic encephalopathy recurrence.

Half as many people are trying heroin, but marijuana use grows

Some good news from the front lines of the heroin crisis: Half as many people tried heroin for the first time in 2017 as in 2016. That's according to data released Friday from the government's annual National Survey on Drug Use and Health.

Read more Medical News

› Verified 9 days ago

Provider NameSusan R. Wiley
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1477725950
PECOS PAC ID: 4183878242
Enrollment ID: I20160205001453

News Archive

Obecure enters into licensing and clinical supply agreement with Grunenthal's subsidiary for XR betahistine

Obecure Ltd (http://www.obecure.com)., a subsidiary of Bio-Light Israeli Life Science Investments Ltd., announced today the execution of a licensing and clinical supply agreement with Farmaceutici Formenti SPA, the Italian Subsidiary of the Grunenthal Group.

USANA Health Sciences congratulates USANA-sponsored Olympian Steve Hooker of Australia

USANA Health Sciences, Inc. would like to congratulate USANA-sponsored Olympian Steve Hooker of Australia for his gold medal finish at the track and field world championships in Berlin, Germany.

First-of-its-kind patient, healthcare provider support program for management of HE

Concentric Pharma Advertising, an independent healthcare advertising and marketing agency, announces the creation of Salix Pharmaceuticals' Hepatic Encephalopathy Living Program. H.E.L.P. launched May 24, 2010, and coincides with the launch of Xifaxan550 (rifaximin) for the management of patients 18 or older at risk for overt hepatic encephalopathy recurrence.

Half as many people are trying heroin, but marijuana use grows

Some good news from the front lines of the heroin crisis: Half as many people tried heroin for the first time in 2017 as in 2016. That's according to data released Friday from the government's annual National Survey on Drug Use and Health.

Read more Medical News

› Verified 9 days ago

Provider NameSalma Chakhachirou
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1457723165
PECOS PAC ID: 9931498458
Enrollment ID: I20160523000851

News Archive

Obecure enters into licensing and clinical supply agreement with Grunenthal's subsidiary for XR betahistine

Obecure Ltd (http://www.obecure.com)., a subsidiary of Bio-Light Israeli Life Science Investments Ltd., announced today the execution of a licensing and clinical supply agreement with Farmaceutici Formenti SPA, the Italian Subsidiary of the Grunenthal Group.

USANA Health Sciences congratulates USANA-sponsored Olympian Steve Hooker of Australia

USANA Health Sciences, Inc. would like to congratulate USANA-sponsored Olympian Steve Hooker of Australia for his gold medal finish at the track and field world championships in Berlin, Germany.

First-of-its-kind patient, healthcare provider support program for management of HE

Concentric Pharma Advertising, an independent healthcare advertising and marketing agency, announces the creation of Salix Pharmaceuticals' Hepatic Encephalopathy Living Program. H.E.L.P. launched May 24, 2010, and coincides with the launch of Xifaxan550 (rifaximin) for the management of patients 18 or older at risk for overt hepatic encephalopathy recurrence.

Half as many people are trying heroin, but marijuana use grows

Some good news from the front lines of the heroin crisis: Half as many people tried heroin for the first time in 2017 as in 2016. That's according to data released Friday from the government's annual National Survey on Drug Use and Health.

Read more Medical News

› Verified 9 days ago

Provider NameRichard S Katz
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1508981069
PECOS PAC ID: 6002079811
Enrollment ID: I20170314000799

News Archive

Obecure enters into licensing and clinical supply agreement with Grunenthal's subsidiary for XR betahistine

Obecure Ltd (http://www.obecure.com)., a subsidiary of Bio-Light Israeli Life Science Investments Ltd., announced today the execution of a licensing and clinical supply agreement with Farmaceutici Formenti SPA, the Italian Subsidiary of the Grunenthal Group.

USANA Health Sciences congratulates USANA-sponsored Olympian Steve Hooker of Australia

USANA Health Sciences, Inc. would like to congratulate USANA-sponsored Olympian Steve Hooker of Australia for his gold medal finish at the track and field world championships in Berlin, Germany.

First-of-its-kind patient, healthcare provider support program for management of HE

Concentric Pharma Advertising, an independent healthcare advertising and marketing agency, announces the creation of Salix Pharmaceuticals' Hepatic Encephalopathy Living Program. H.E.L.P. launched May 24, 2010, and coincides with the launch of Xifaxan550 (rifaximin) for the management of patients 18 or older at risk for overt hepatic encephalopathy recurrence.

Half as many people are trying heroin, but marijuana use grows

Some good news from the front lines of the heroin crisis: Half as many people tried heroin for the first time in 2017 as in 2016. That's according to data released Friday from the government's annual National Survey on Drug Use and Health.

Read more Medical News

› Verified 9 days ago

Provider NameColumbia T Herzlinger
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1750810396
PECOS PAC ID: 2264798651
Enrollment ID: I20171130000130

News Archive

Obecure enters into licensing and clinical supply agreement with Grunenthal's subsidiary for XR betahistine

Obecure Ltd (http://www.obecure.com)., a subsidiary of Bio-Light Israeli Life Science Investments Ltd., announced today the execution of a licensing and clinical supply agreement with Farmaceutici Formenti SPA, the Italian Subsidiary of the Grunenthal Group.

USANA Health Sciences congratulates USANA-sponsored Olympian Steve Hooker of Australia

USANA Health Sciences, Inc. would like to congratulate USANA-sponsored Olympian Steve Hooker of Australia for his gold medal finish at the track and field world championships in Berlin, Germany.

First-of-its-kind patient, healthcare provider support program for management of HE

Concentric Pharma Advertising, an independent healthcare advertising and marketing agency, announces the creation of Salix Pharmaceuticals' Hepatic Encephalopathy Living Program. H.E.L.P. launched May 24, 2010, and coincides with the launch of Xifaxan550 (rifaximin) for the management of patients 18 or older at risk for overt hepatic encephalopathy recurrence.

Half as many people are trying heroin, but marijuana use grows

Some good news from the front lines of the heroin crisis: Half as many people tried heroin for the first time in 2017 as in 2016. That's according to data released Friday from the government's annual National Survey on Drug Use and Health.

Read more Medical News

› Verified 9 days ago

Provider NameJennifer Candelaria Lee
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1255715082
PECOS PAC ID: 0042526055
Enrollment ID: I20180214002059

News Archive

Obecure enters into licensing and clinical supply agreement with Grunenthal's subsidiary for XR betahistine

Obecure Ltd (http://www.obecure.com)., a subsidiary of Bio-Light Israeli Life Science Investments Ltd., announced today the execution of a licensing and clinical supply agreement with Farmaceutici Formenti SPA, the Italian Subsidiary of the Grunenthal Group.

USANA Health Sciences congratulates USANA-sponsored Olympian Steve Hooker of Australia

USANA Health Sciences, Inc. would like to congratulate USANA-sponsored Olympian Steve Hooker of Australia for his gold medal finish at the track and field world championships in Berlin, Germany.

First-of-its-kind patient, healthcare provider support program for management of HE

Concentric Pharma Advertising, an independent healthcare advertising and marketing agency, announces the creation of Salix Pharmaceuticals' Hepatic Encephalopathy Living Program. H.E.L.P. launched May 24, 2010, and coincides with the launch of Xifaxan550 (rifaximin) for the management of patients 18 or older at risk for overt hepatic encephalopathy recurrence.

Half as many people are trying heroin, but marijuana use grows

Some good news from the front lines of the heroin crisis: Half as many people tried heroin for the first time in 2017 as in 2016. That's according to data released Friday from the government's annual National Survey on Drug Use and Health.

Read more Medical News

› Verified 9 days ago

Provider NameLaura Leslie Brykczynski
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1750452926
PECOS PAC ID: 9931469863
Enrollment ID: I20180305000069

News Archive

Obecure enters into licensing and clinical supply agreement with Grunenthal's subsidiary for XR betahistine

Obecure Ltd (http://www.obecure.com)., a subsidiary of Bio-Light Israeli Life Science Investments Ltd., announced today the execution of a licensing and clinical supply agreement with Farmaceutici Formenti SPA, the Italian Subsidiary of the Grunenthal Group.

USANA Health Sciences congratulates USANA-sponsored Olympian Steve Hooker of Australia

USANA Health Sciences, Inc. would like to congratulate USANA-sponsored Olympian Steve Hooker of Australia for his gold medal finish at the track and field world championships in Berlin, Germany.

First-of-its-kind patient, healthcare provider support program for management of HE

Concentric Pharma Advertising, an independent healthcare advertising and marketing agency, announces the creation of Salix Pharmaceuticals' Hepatic Encephalopathy Living Program. H.E.L.P. launched May 24, 2010, and coincides with the launch of Xifaxan550 (rifaximin) for the management of patients 18 or older at risk for overt hepatic encephalopathy recurrence.

Half as many people are trying heroin, but marijuana use grows

Some good news from the front lines of the heroin crisis: Half as many people tried heroin for the first time in 2017 as in 2016. That's according to data released Friday from the government's annual National Survey on Drug Use and Health.

Read more Medical News

› Verified 9 days ago

Provider NameKwon Jung Choe
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1548344914
PECOS PAC ID: 7810170297
Enrollment ID: I20180305000141

News Archive

Obecure enters into licensing and clinical supply agreement with Grunenthal's subsidiary for XR betahistine

Obecure Ltd (http://www.obecure.com)., a subsidiary of Bio-Light Israeli Life Science Investments Ltd., announced today the execution of a licensing and clinical supply agreement with Farmaceutici Formenti SPA, the Italian Subsidiary of the Grunenthal Group.

USANA Health Sciences congratulates USANA-sponsored Olympian Steve Hooker of Australia

USANA Health Sciences, Inc. would like to congratulate USANA-sponsored Olympian Steve Hooker of Australia for his gold medal finish at the track and field world championships in Berlin, Germany.

First-of-its-kind patient, healthcare provider support program for management of HE

Concentric Pharma Advertising, an independent healthcare advertising and marketing agency, announces the creation of Salix Pharmaceuticals' Hepatic Encephalopathy Living Program. H.E.L.P. launched May 24, 2010, and coincides with the launch of Xifaxan550 (rifaximin) for the management of patients 18 or older at risk for overt hepatic encephalopathy recurrence.

Half as many people are trying heroin, but marijuana use grows

Some good news from the front lines of the heroin crisis: Half as many people tried heroin for the first time in 2017 as in 2016. That's according to data released Friday from the government's annual National Survey on Drug Use and Health.

Read more Medical News

› Verified 9 days ago

Provider NameShannon Sumi Suh
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1407945819
PECOS PAC ID: 1254381130
Enrollment ID: I20180601000064

News Archive

Obecure enters into licensing and clinical supply agreement with Grunenthal's subsidiary for XR betahistine

Obecure Ltd (http://www.obecure.com)., a subsidiary of Bio-Light Israeli Life Science Investments Ltd., announced today the execution of a licensing and clinical supply agreement with Farmaceutici Formenti SPA, the Italian Subsidiary of the Grunenthal Group.

USANA Health Sciences congratulates USANA-sponsored Olympian Steve Hooker of Australia

USANA Health Sciences, Inc. would like to congratulate USANA-sponsored Olympian Steve Hooker of Australia for his gold medal finish at the track and field world championships in Berlin, Germany.

First-of-its-kind patient, healthcare provider support program for management of HE

Concentric Pharma Advertising, an independent healthcare advertising and marketing agency, announces the creation of Salix Pharmaceuticals' Hepatic Encephalopathy Living Program. H.E.L.P. launched May 24, 2010, and coincides with the launch of Xifaxan550 (rifaximin) for the management of patients 18 or older at risk for overt hepatic encephalopathy recurrence.

Half as many people are trying heroin, but marijuana use grows

Some good news from the front lines of the heroin crisis: Half as many people tried heroin for the first time in 2017 as in 2016. That's according to data released Friday from the government's annual National Survey on Drug Use and Health.

Read more Medical News

› Verified 9 days ago

Provider NameDemet Denise Tunc
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1356552681
PECOS PAC ID: 4688917099
Enrollment ID: I20190618003438

News Archive

Obecure enters into licensing and clinical supply agreement with Grunenthal's subsidiary for XR betahistine

Obecure Ltd (http://www.obecure.com)., a subsidiary of Bio-Light Israeli Life Science Investments Ltd., announced today the execution of a licensing and clinical supply agreement with Farmaceutici Formenti SPA, the Italian Subsidiary of the Grunenthal Group.

USANA Health Sciences congratulates USANA-sponsored Olympian Steve Hooker of Australia

USANA Health Sciences, Inc. would like to congratulate USANA-sponsored Olympian Steve Hooker of Australia for his gold medal finish at the track and field world championships in Berlin, Germany.

First-of-its-kind patient, healthcare provider support program for management of HE

Concentric Pharma Advertising, an independent healthcare advertising and marketing agency, announces the creation of Salix Pharmaceuticals' Hepatic Encephalopathy Living Program. H.E.L.P. launched May 24, 2010, and coincides with the launch of Xifaxan550 (rifaximin) for the management of patients 18 or older at risk for overt hepatic encephalopathy recurrence.

Half as many people are trying heroin, but marijuana use grows

Some good news from the front lines of the heroin crisis: Half as many people tried heroin for the first time in 2017 as in 2016. That's according to data released Friday from the government's annual National Survey on Drug Use and Health.

Read more Medical News

› Verified 9 days ago

Provider NameMichelle Nishku
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1922664564
PECOS PAC ID: 3971838079
Enrollment ID: I20190725003159

News Archive

Obecure enters into licensing and clinical supply agreement with Grunenthal's subsidiary for XR betahistine

Obecure Ltd (http://www.obecure.com)., a subsidiary of Bio-Light Israeli Life Science Investments Ltd., announced today the execution of a licensing and clinical supply agreement with Farmaceutici Formenti SPA, the Italian Subsidiary of the Grunenthal Group.

USANA Health Sciences congratulates USANA-sponsored Olympian Steve Hooker of Australia

USANA Health Sciences, Inc. would like to congratulate USANA-sponsored Olympian Steve Hooker of Australia for his gold medal finish at the track and field world championships in Berlin, Germany.

First-of-its-kind patient, healthcare provider support program for management of HE

Concentric Pharma Advertising, an independent healthcare advertising and marketing agency, announces the creation of Salix Pharmaceuticals' Hepatic Encephalopathy Living Program. H.E.L.P. launched May 24, 2010, and coincides with the launch of Xifaxan550 (rifaximin) for the management of patients 18 or older at risk for overt hepatic encephalopathy recurrence.

Half as many people are trying heroin, but marijuana use grows

Some good news from the front lines of the heroin crisis: Half as many people tried heroin for the first time in 2017 as in 2016. That's according to data released Friday from the government's annual National Survey on Drug Use and Health.

Read more Medical News

› Verified 9 days ago

Provider NamePolin Lay
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1699334201
PECOS PAC ID: 2163757063
Enrollment ID: I20190729002193

News Archive

Obecure enters into licensing and clinical supply agreement with Grunenthal's subsidiary for XR betahistine

Obecure Ltd (http://www.obecure.com)., a subsidiary of Bio-Light Israeli Life Science Investments Ltd., announced today the execution of a licensing and clinical supply agreement with Farmaceutici Formenti SPA, the Italian Subsidiary of the Grunenthal Group.

USANA Health Sciences congratulates USANA-sponsored Olympian Steve Hooker of Australia

USANA Health Sciences, Inc. would like to congratulate USANA-sponsored Olympian Steve Hooker of Australia for his gold medal finish at the track and field world championships in Berlin, Germany.

First-of-its-kind patient, healthcare provider support program for management of HE

Concentric Pharma Advertising, an independent healthcare advertising and marketing agency, announces the creation of Salix Pharmaceuticals' Hepatic Encephalopathy Living Program. H.E.L.P. launched May 24, 2010, and coincides with the launch of Xifaxan550 (rifaximin) for the management of patients 18 or older at risk for overt hepatic encephalopathy recurrence.

Half as many people are trying heroin, but marijuana use grows

Some good news from the front lines of the heroin crisis: Half as many people tried heroin for the first time in 2017 as in 2016. That's according to data released Friday from the government's annual National Survey on Drug Use and Health.

Read more Medical News

› Verified 9 days ago

Provider NameTina Douroudian
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1154762144
PECOS PAC ID: 0941432306
Enrollment ID: I20190813002525

News Archive

Obecure enters into licensing and clinical supply agreement with Grunenthal's subsidiary for XR betahistine

Obecure Ltd (http://www.obecure.com)., a subsidiary of Bio-Light Israeli Life Science Investments Ltd., announced today the execution of a licensing and clinical supply agreement with Farmaceutici Formenti SPA, the Italian Subsidiary of the Grunenthal Group.

USANA Health Sciences congratulates USANA-sponsored Olympian Steve Hooker of Australia

USANA Health Sciences, Inc. would like to congratulate USANA-sponsored Olympian Steve Hooker of Australia for his gold medal finish at the track and field world championships in Berlin, Germany.

First-of-its-kind patient, healthcare provider support program for management of HE

Concentric Pharma Advertising, an independent healthcare advertising and marketing agency, announces the creation of Salix Pharmaceuticals' Hepatic Encephalopathy Living Program. H.E.L.P. launched May 24, 2010, and coincides with the launch of Xifaxan550 (rifaximin) for the management of patients 18 or older at risk for overt hepatic encephalopathy recurrence.

Half as many people are trying heroin, but marijuana use grows

Some good news from the front lines of the heroin crisis: Half as many people tried heroin for the first time in 2017 as in 2016. That's according to data released Friday from the government's annual National Survey on Drug Use and Health.

Read more Medical News

› Verified 9 days ago

Provider NameChinweuba Obi
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1548638810
PECOS PAC ID: 2062720543
Enrollment ID: I20200610001025

News Archive

Obecure enters into licensing and clinical supply agreement with Grunenthal's subsidiary for XR betahistine

Obecure Ltd (http://www.obecure.com)., a subsidiary of Bio-Light Israeli Life Science Investments Ltd., announced today the execution of a licensing and clinical supply agreement with Farmaceutici Formenti SPA, the Italian Subsidiary of the Grunenthal Group.

USANA Health Sciences congratulates USANA-sponsored Olympian Steve Hooker of Australia

USANA Health Sciences, Inc. would like to congratulate USANA-sponsored Olympian Steve Hooker of Australia for his gold medal finish at the track and field world championships in Berlin, Germany.

First-of-its-kind patient, healthcare provider support program for management of HE

Concentric Pharma Advertising, an independent healthcare advertising and marketing agency, announces the creation of Salix Pharmaceuticals' Hepatic Encephalopathy Living Program. H.E.L.P. launched May 24, 2010, and coincides with the launch of Xifaxan550 (rifaximin) for the management of patients 18 or older at risk for overt hepatic encephalopathy recurrence.

Half as many people are trying heroin, but marijuana use grows

Some good news from the front lines of the heroin crisis: Half as many people tried heroin for the first time in 2017 as in 2016. That's according to data released Friday from the government's annual National Survey on Drug Use and Health.

Read more Medical News

› Verified 9 days ago

Provider NameGooya Goudarzi
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1598222457
PECOS PAC ID: 4789910076
Enrollment ID: I20200918000052

News Archive

Obecure enters into licensing and clinical supply agreement with Grunenthal's subsidiary for XR betahistine

Obecure Ltd (http://www.obecure.com)., a subsidiary of Bio-Light Israeli Life Science Investments Ltd., announced today the execution of a licensing and clinical supply agreement with Farmaceutici Formenti SPA, the Italian Subsidiary of the Grunenthal Group.

USANA Health Sciences congratulates USANA-sponsored Olympian Steve Hooker of Australia

USANA Health Sciences, Inc. would like to congratulate USANA-sponsored Olympian Steve Hooker of Australia for his gold medal finish at the track and field world championships in Berlin, Germany.

First-of-its-kind patient, healthcare provider support program for management of HE

Concentric Pharma Advertising, an independent healthcare advertising and marketing agency, announces the creation of Salix Pharmaceuticals' Hepatic Encephalopathy Living Program. H.E.L.P. launched May 24, 2010, and coincides with the launch of Xifaxan550 (rifaximin) for the management of patients 18 or older at risk for overt hepatic encephalopathy recurrence.

Half as many people are trying heroin, but marijuana use grows

Some good news from the front lines of the heroin crisis: Half as many people tried heroin for the first time in 2017 as in 2016. That's according to data released Friday from the government's annual National Survey on Drug Use and Health.

Read more Medical News

› Verified 9 days ago

Provider NameMelani Cruz
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1487121232
PECOS PAC ID: 3072918176
Enrollment ID: I20210827002078

News Archive

Obecure enters into licensing and clinical supply agreement with Grunenthal's subsidiary for XR betahistine

Obecure Ltd (http://www.obecure.com)., a subsidiary of Bio-Light Israeli Life Science Investments Ltd., announced today the execution of a licensing and clinical supply agreement with Farmaceutici Formenti SPA, the Italian Subsidiary of the Grunenthal Group.

USANA Health Sciences congratulates USANA-sponsored Olympian Steve Hooker of Australia

USANA Health Sciences, Inc. would like to congratulate USANA-sponsored Olympian Steve Hooker of Australia for his gold medal finish at the track and field world championships in Berlin, Germany.

First-of-its-kind patient, healthcare provider support program for management of HE

Concentric Pharma Advertising, an independent healthcare advertising and marketing agency, announces the creation of Salix Pharmaceuticals' Hepatic Encephalopathy Living Program. H.E.L.P. launched May 24, 2010, and coincides with the launch of Xifaxan550 (rifaximin) for the management of patients 18 or older at risk for overt hepatic encephalopathy recurrence.

Half as many people are trying heroin, but marijuana use grows

Some good news from the front lines of the heroin crisis: Half as many people tried heroin for the first time in 2017 as in 2016. That's according to data released Friday from the government's annual National Survey on Drug Use and Health.

Read more Medical News

› Verified 9 days ago

Provider NameKrista Lynn Greene
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1396277885
PECOS PAC ID: 0941674287
Enrollment ID: I20230329000729

News Archive

Obecure enters into licensing and clinical supply agreement with Grunenthal's subsidiary for XR betahistine

Obecure Ltd (http://www.obecure.com)., a subsidiary of Bio-Light Israeli Life Science Investments Ltd., announced today the execution of a licensing and clinical supply agreement with Farmaceutici Formenti SPA, the Italian Subsidiary of the Grunenthal Group.

USANA Health Sciences congratulates USANA-sponsored Olympian Steve Hooker of Australia

USANA Health Sciences, Inc. would like to congratulate USANA-sponsored Olympian Steve Hooker of Australia for his gold medal finish at the track and field world championships in Berlin, Germany.

First-of-its-kind patient, healthcare provider support program for management of HE

Concentric Pharma Advertising, an independent healthcare advertising and marketing agency, announces the creation of Salix Pharmaceuticals' Hepatic Encephalopathy Living Program. H.E.L.P. launched May 24, 2010, and coincides with the launch of Xifaxan550 (rifaximin) for the management of patients 18 or older at risk for overt hepatic encephalopathy recurrence.

Half as many people are trying heroin, but marijuana use grows

Some good news from the front lines of the heroin crisis: Half as many people tried heroin for the first time in 2017 as in 2016. That's according to data released Friday from the government's annual National Survey on Drug Use and Health.

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. My Eye Dr. is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
My Eye Dr.
8614 Westwood Center Dr Fl 9,
Vienna, VA 22182-2442

Ph: (703) 847-8899
My Eye Dr.
9675 Liberia Ave, # 108,
Manassas, VA 20110-1741

Ph: (703) 331-2122

News Archive

Obecure enters into licensing and clinical supply agreement with Grunenthal's subsidiary for XR betahistine

Obecure Ltd (http://www.obecure.com)., a subsidiary of Bio-Light Israeli Life Science Investments Ltd., announced today the execution of a licensing and clinical supply agreement with Farmaceutici Formenti SPA, the Italian Subsidiary of the Grunenthal Group.

USANA Health Sciences congratulates USANA-sponsored Olympian Steve Hooker of Australia

USANA Health Sciences, Inc. would like to congratulate USANA-sponsored Olympian Steve Hooker of Australia for his gold medal finish at the track and field world championships in Berlin, Germany.

First-of-its-kind patient, healthcare provider support program for management of HE

Concentric Pharma Advertising, an independent healthcare advertising and marketing agency, announces the creation of Salix Pharmaceuticals' Hepatic Encephalopathy Living Program. H.E.L.P. launched May 24, 2010, and coincides with the launch of Xifaxan550 (rifaximin) for the management of patients 18 or older at risk for overt hepatic encephalopathy recurrence.

Half as many people are trying heroin, but marijuana use grows

Some good news from the front lines of the heroin crisis: Half as many people tried heroin for the first time in 2017 as in 2016. That's according to data released Friday from the government's annual National Survey on Drug Use and Health.

Read more News

› Verified 9 days ago


Optometrist in Manassas, VA

Dr. Peter Tien Dzung Pham, O.D.
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 8300 Sudley Rd, Ste I-6, Manassas, VA 20109
Phone: 850-384-1554    
Dr. Mylynn Cheung, O.D.
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 7412 Stream Walk Ln, Manassas, VA 20109
Phone: 703-368-5557    Fax: 703-330-7659
Dr. Elena C Byrnes, OD
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 8912 Centreville Rd, Manassas, VA 20110
Phone: 703-361-6151    Fax: 703-361-1750
Orbal Mariam Anwari,
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 9405 Liberia Ave, Manassas, VA 20110
Phone: 703-722-4915    
Dr. Thomas B Wood, OD
Optometrist
Medicare: Medicare Enrolled
Practice Location: 10660 Crestwood Dr, Manassas, VA 20109
Phone: 703-369-3937    Fax: 703-369-7147
Joseph V. Otto, O.D.
Optometrist
Medicare: Medicare Enrolled
Practice Location: 7519 Presidential Ln, Manassas, VA 20109
Phone: 703-257-7587    
Drs. Panner & Wen, Pc
Optometrist
Medicare: Medicare Enrolled
Practice Location: 8140 Ashton Ave, Suite 115, Manassas, VA 20109
Phone: 703-361-8284    Fax: 703-361-0318

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.